title: Intraocular inflammation with intravitreal bevacizumab (Avastin).
authors.forename: Muhammad S
authors.initials: MS
authors.lastname: Raja
authors.forename: Craig
authors.initials: C
authors.lastname: Goldsmith
authors.forename: Benjamin J L
authors.initials: BJ
authors.lastname: Burton
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D014605:Uveitis / Q000139:chemically induced*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab